BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.51
0.00 (0.00%)
At close: May 15, 2026, 4:00 PM EDT
8.40
-0.11 (-1.29%)
After-hours: May 15, 2026, 7:41 PM EDT
BBOT Market Cap
BBOT has a market cap or net worth of $681.08 million as of May 15, 2026. Its market cap has increased by 231.97% in one year.
Market Cap
681.08M
Enterprise Value
431.45M
1-Year Change
231.97%
Ranking
Category
Stock Price
$8.51
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $239.56M to $681.08M, an increase of 184.31%. That is a compound annual growth rate of 58.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 681.07M | 131.40% |
| Dec 31, 2025 | 294.33M | 48.25% |
| Dec 31, 2024 | 198.54M | -17.12% |
| Feb 9, 2024 | 239.56M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARS Pharmaceuticals | 737.31M |
| Relmada Therapeutics | 723.73M |
| Eikon Therapeutics | 717.34M |
| Tenax Therapeutics | 705.36M |
| Allogene Therapeutics | 690.31M |
| Solid Biosciences | 681.27M |
| Crescent Biopharma | 663.92M |
| Zevra Therapeutics | 650.86M |